Molecular Partners says MP0632 preclinical data at SITC 2026 show no impact on healthy cells, supporting IND-enabling studies

Molecular Partners says preclinical data for MP0632 presented at SITC 2026 showed no detectable impact on healthy mesothelial or epithelial cells, supporting IND-enabling studies in MSLN and EpCAM solid tumors.

Detected & updated continuously · Source: Nebula